Participants 298 363 4
patients with diarrhea-dominant irritable bowel syndrome (IBS-D).
Participants 640 657 3
in IBS-D patients
Participants 717 797 3
Thirty-seven patients received S. boulardii and 35 patients received the placebo
Participants 1847 1867 3
 patients with IBS-D
